Home » Sanofi’s Lantus Cuts Blood Sugar More Than Merck’s Januvia
Sanofi’s Lantus Cuts Blood Sugar More Than Merck’s Januvia
Sanofi’s Lantus insulin reduced blood-sugar levels to a greater degree than Merck’s Januvia in people with Type 2 diabetes in a clinical trial.
The Wall Street Journal
The Wall Street Journal
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May